| Josie M Ullsperger, PHD | |
|
2275 Deming Way Ste 180, Middleton, WI 53562-5527 | |
| (608) 282-8200 | |
| (608) 262-9246 |
| Full Name | Josie M Ullsperger |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 4 Years |
| Location | 2275 Deming Way Ste 180, Middleton, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912679697 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 3981-57 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Wisconsin Medical Foundation Inc | 6608785464 | 2164 |
News Archive
Battlefield corpsmen and medical professionals across the country gained a valuable tool last week, as the Food and Drug Administration approved the first hand-held device to detect life-threatening bleeding in the brain.
In its review of the BLA, the FDA stated the T-DM1 trials did not meet the standard for accelerated approval because all available treatment choices approved for metastatic breast cancer, regardless of HER2 status, had not been exhausted in the study population.
Men with relatively unaggressive prostate tumors and whose disease is carefully monitored by urologists are unlikely to develop metastatic prostate cancer or die of their cancers, according to results of a study by researchers at the Brady Urological Institute at Johns Hopkins, who analyzed survival statistics up to 15 years.
Researchers from the New York University Tandon School of Engineering and Politecnico di Torino, Italy, have developed a mathematical model that could cure the potential to underestimate how quickly diseases spread.
XTL Biopharmaceuticals Ltd. has announced the top-line results from the Bicifadine Phase 2b clinical trial for the treatment of diabetic neuropathic pain.
› Verified 6 days ago
| Entity Name | University Of Wisconsin Medical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598784555 PECOS PAC ID: 6608785464 Enrollment ID: O20031111000435 |
News Archive
Battlefield corpsmen and medical professionals across the country gained a valuable tool last week, as the Food and Drug Administration approved the first hand-held device to detect life-threatening bleeding in the brain.
In its review of the BLA, the FDA stated the T-DM1 trials did not meet the standard for accelerated approval because all available treatment choices approved for metastatic breast cancer, regardless of HER2 status, had not been exhausted in the study population.
Men with relatively unaggressive prostate tumors and whose disease is carefully monitored by urologists are unlikely to develop metastatic prostate cancer or die of their cancers, according to results of a study by researchers at the Brady Urological Institute at Johns Hopkins, who analyzed survival statistics up to 15 years.
Researchers from the New York University Tandon School of Engineering and Politecnico di Torino, Italy, have developed a mathematical model that could cure the potential to underestimate how quickly diseases spread.
XTL Biopharmaceuticals Ltd. has announced the top-line results from the Bicifadine Phase 2b clinical trial for the treatment of diabetic neuropathic pain.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Josie M Ullsperger, PHD 7974 Uw Health Ct, Middleton, WI 53562-5531 Ph: () - | Josie M Ullsperger, PHD 2275 Deming Way Ste 180, Middleton, WI 53562-5527 Ph: (608) 282-8200 |
News Archive
Battlefield corpsmen and medical professionals across the country gained a valuable tool last week, as the Food and Drug Administration approved the first hand-held device to detect life-threatening bleeding in the brain.
In its review of the BLA, the FDA stated the T-DM1 trials did not meet the standard for accelerated approval because all available treatment choices approved for metastatic breast cancer, regardless of HER2 status, had not been exhausted in the study population.
Men with relatively unaggressive prostate tumors and whose disease is carefully monitored by urologists are unlikely to develop metastatic prostate cancer or die of their cancers, according to results of a study by researchers at the Brady Urological Institute at Johns Hopkins, who analyzed survival statistics up to 15 years.
Researchers from the New York University Tandon School of Engineering and Politecnico di Torino, Italy, have developed a mathematical model that could cure the potential to underestimate how quickly diseases spread.
XTL Biopharmaceuticals Ltd. has announced the top-line results from the Bicifadine Phase 2b clinical trial for the treatment of diabetic neuropathic pain.
› Verified 6 days ago
Leah Barr, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2711 Allen Blvd Ste 300, Middleton, WI 53562 Phone: 608-622-7030 | |
James K Gerndt, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 6300 University Ave, Suite 25, Middleton, WI 53562 Phone: 608-237-8000 Fax: 608-237-8005 | |
Lisa B Mcguffey, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3535 John Muir Dr, Middleton, WI 53562 Phone: 608-287-6084 | |
Dr. Katherine Anne Watermolen, PSY.D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2275 Deming Way Ste 180, Middleton, WI 53562 Phone: 608-282-8200 Fax: 608-262-9246 | |
Dr. Margrett Christine Sampe, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2275 Deming Way Ste 180, Middleton, WI 53562 Phone: 608-282-8200 Fax: 608-262-9246 | |
Jane B. Gogan, PHD, ABPP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3015 Woodland Trl, Middleton, WI 53562 Phone: 608-467-3412 | |
Dr. Kristen Wilkinson, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2365 Deming Way, Middleton, WI 53562 Phone: 608-824-6160 Fax: 608-827-3040 |